The Quantellect read.As of Nov 19, 2026, 9 active firms cover Healthcare Realty Trust Incorporated: 3 rate it Buy or better, 6 sit at Neutral, and 0 rate it Sell or worse, a neutral consensus. Targets are tightly clustered, $18.00 to $24.00, so the covering firms are broadly aligned. The average target of $21.11 sits 9% above the current $19.38. The rating mix has stayed broadly stable, with Buy-side ratings easing from 4 to 3 over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.01 next quarter toward $0.04 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS9 active firms
Neutral
Strong Buy00%
Buy333%
Neutral667%
Sell00%
Strong Sell00%
Based on 9 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$21.11
+9.0% upside
Average target across 9 active firms as of Nov 19, 2026 vs $19.38 current
Highest Target$24.00
Average Target$21.11
Lowest Target$18.00
Detailed analyst forecasts for HR
Showing 1–9 of 9 named analysts shown · 9 active firms in the rating projection
As of Nov 19, 2026, 3 of 9 active firms rate HR a Buy (6 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
HR EPS & revenue forecast
EPS · NEXT QUARTER
$0.01
Range $0.00 – $0.01 · 2 analysts
Next period, 2 analysts expect Healthcare Realty Trust Incorporated to earn $0.01 a share (range $0.00 – $0.01), versus — a year earlier. Full-year consensus is $-0.14, growing to $0.04 the year after.
REVENUE · NEXT QUARTER
$288.1M
Range $286.5M – $289.7M · 2 analysts · +3% YoY
Revenue is expected to reach $288.1M (range $286.5M – $289.7M), +3.3% year-over-year. Full-year consensus is $1.1B, rising to $1.2B next year.
Top analysts covering Healthcare Realty Trust Incorporated
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on HR.
#1
Jonathan Hughes
Raymond James · Rank #42
Sell
No targeton HR
Overall win rate
52%
+ Follow
#2
Nicholas Yulico
Scotiabank · Rank #77
Buy
$22.00+13.5% to target
Overall win rate
53%
+ Follow
#3
John Kilichowski
Wells Fargo · Rank #103
Neutral
$20.00+3.2% to target
Overall win rate
50%
+ Follow
#4
Paul Choi
Goldman Sachs · Rank #110
Neutral
$14.00-27.7% to target
Overall win rate
52%
+ Follow
#5
Michael Carroll
RBC Capital
Neutral
$22.00+13.5% to target
Coverage
—
+ Follow
HR stock forecast FAQ
What is HR's average 12-month price target?+
The 9 active firms with a live target average $21.11 for Healthcare Realty Trust Incorporated over the next 12 months, ranging from a $24.00 high to a $18.00 low, as of Nov 19, 2026.
Is HR stock a Buy, Sell or Neutral right now?+
The current consensus is Neutral. Of the 9 active firms as of Nov 19, 2026, 3 rate it Buy or Strong Buy, 6 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for HR?+
The Street-high target is $24.00 (Cantor Fitzgerald), and the Street-low is $18.00 (Wells Fargo). The average of all 9 active-firm targets is $21.11.
How many active Wall Street firms cover HR?+
9 active firms have a recognized rating on Healthcare Realty Trust Incorporated as of Nov 19, 2026, and 9 active firms carry a live 12-month price target.
Who is the most accurate analyst covering HR?+
Among analysts who currently cover HR, Jonathan Hughes of Raymond James has the strongest overall Quantellect track record (Rank #42). Their current call is Sell.
What is Healthcare Realty Trust Incorporated's projected EPS for next quarter?+
The consensus estimate is $0.01 per share (range $0.00 – $0.01) across 2 analysts. Full-year EPS is projected at $-0.14, rising to $0.04 the following year.
How much revenue is Healthcare Realty Trust Incorporated expected to report next quarter?+
Consensus revenue is $288.1M (range $286.5M – $289.7M). Full-year revenue is projected at $1.1B, growing to $1.2B next year.
Have analysts been upgrading or downgrading HR lately?+
As of Nov 19, 2026, 3 of 9 active firms rate HR a Buy (6 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their HR calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.